Emerald Health Therapeutics Inc (EMH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 8 | 6 | 9 | 18 | 10 |
| Accounts receivable | -5 | -37 | -9 | -13 | 47 |
| Other Working Capital | -51 | -13 | -49 | 26 | 51 |
| Other Operating Activity | -700 | -383 | -19 | -77 | -62 |
| Operating Cash Flow | $-749 | $-428 | $-68 | $-46 | $46 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -83 | -70 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 100 | 0 |
| Investing Cash Flow | $-83 | $-70 | $0 | $100 | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -33 | -5 | N/A | N/A | 0 |
| Common Stock Issued | -414 | 2,586 | N/A | N/A | N/A |
| Other Financing Activity | 524 | 0 | 0 | -100 | 0 |
| Financing Cash Flow | $77 | $2,581 | $0 | $-100 | $0 |
| Beginning Cash Position | 2,474 | 391 | 138 | 183 | 137 |
| End Cash Position | 1,719 | 2,474 | 70 | 138 | 183 |
| Net Cash Flow | $-756 | $2,083 | $-68 | $-46 | $46 |
| Free Cash Flow | |||||
| Operating Cash Flow | -749 | -428 | -68 | -46 | 46 |
| Capital Expenditure | -83 | -70 | N/A | N/A | N/A |
| Free Cash Flow | -832 | -497 | -68 | -46 | 46 |